Binge Eating Disorder Treatment Study - Full Text View

Sponsored by:	Ottawa Hospital Research Institute
Information provided by:	Ottawa Hospital Research Institute
ClinicalTrials.gov Identifier:	NCT00848367

Purpose

The main objective of the proposed study is to determine whether the effectiveness of a group therapy treatment for Binge Eating Disorder (BED) is improved and attrition reduced by optimally matching women with BED who have high attachment anxiety to Group Psychodynamic Interpersonal Psychotherapy (GPIP). This study represents the next phase in a program of research stemming from a previously conducted randomized controlled trial (RCT).

Condition	Intervention
Binge Eating Disorder	Behavioral: Group Psychodynamic Interpersonal Therapy

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Single Blind (Subject), Parallel Assignment
Official Title:	Optimizing Outcomes for Binge Eating, Depression and Weight Loss for Obese Women With Binge Eating Disorder by Matching to Group Psychological Treatments Based on Level of Attachment Anxiety

Resource links provided by NLM:

MedlinePlus related topics: Anxiety Depression Eating Disorders

U.S. FDA Resources

Further study details as provided by Ottawa Hospital Research Institute:

Primary Outcome Measures:

Frequency of binge eating in the Past 28 days [ Time Frame: Pre and Post treatment, 6 months and 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Earlier response to treatment including lowered BMI, a greater reduction in depression, and more positive change in reported quality of life [ Time Frame: Pre and Post treatment, 6 months and 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment:	120
Study Start Date:	April 2007
Estimated Study Completion Date:	December 2010
Estimated Primary Completion Date:	September 2010 (Final data collection date for primary outcome measure)

Intervention Details:

16 weeks of group therapy for patients with Binge Eating Disorder, matching them by attachment anxiety dimensions in order to enhance the impact of the therapy. It is hypothesized that by optimally matching patients to groups, they will have better clinical and health outcomes.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Overweight Women 18 years of age or older who binge eat at least twice per week for the past month.

Exclusion Criteria:

unable speak English
history of an eating disorder other than Binge Eating Disorder
concurrent DSM-IV diagnosis of bipolar disorder, psychosis, drug or alcohol problem
pregnant or planning on becoming pregnant within the next year
are currently or plan to become enrolled in a weight loss program within the next year

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00848367

Locations

Canada, Ontario
Regional Centre for the Treatment of Eating Disorders- Ottawa Hospital-General Campus
Ottawa, Ontario, Canada, K2J3J4

Sponsors and Collaborators

Ottawa Hospital Research Institute

Investigators

Principal Investigator:

Giorgio Tasca, Ph.D.C.Psych

University of Ottawa, Ottawa Hospital-General Campus

More Information

No publications provided

Responsible Party:	Ottawa Health Research Institute ( George Tasca )
Study ID Numbers:	OHREB 2007254-01H
Study First Received:	February 19, 2009
Last Updated:	July 8, 2009
ClinicalTrials.gov Identifier:	NCT00848367 History of Changes
Health Authority:	Canada: Canadian Institutes of Health Research

Study placed in the following topic categories:

Body Weight
Signs and Symptoms
Bulimia Nervosa
Obesity
Depression
Signs and Symptoms, Digestive

Mental Disorders
Bulimia
Weight Loss
Depressive Disorder
Eating Disorders
Hyperphagia

Additional relevant MeSH terms:

Signs and Symptoms
Bulimia Nervosa
Pathologic Processes
Disease
Signs and Symptoms, Digestive

Mental Disorders
Bulimia
Eating Disorders
Hyperphagia

ClinicalTrials.gov processed this record on August 30, 2009